Here are seven key notes on spine and orthopedic device companies from the past week:
Spinal Tech
Fifteen leadership changes executed or announced by orthopedic and spine device companies in the past 90 days:
Medtronic USA will pay over $9.2 million to settle allegations that it footed the bill for expensive events benefiting South Dakota neurosurgeon Wilson Asfora, MD, to induce him to use certain implantable devices, the Department of Justice announced Oct. 29.
Chris Lo and Chloe Kent, writers at Medical Device Network, discussed the viability of single-use medical devices due to the COVID-19 pandemic. Here are key points from each side of the Oct. 27 opinion piece:
CMS proposed Medicare coverage and payment policy changes on Oct. 27 for durable medical equipment, prosthetics, orthotic devices and supplies.
In a Sept. 29 letter to shareholders, Medtronic CEO Geoff Martha reflected on financial challenges created by the COVID-19 pandemic and outlined the company's strategy going forward.
The orthopedic industry has continued to drive innovation in the surgical field this year, with artificial intelligence, augmented reality, robotics and 3D printing taking center stage.
Here's how Medtronic, Stryker and Johnson & Johnson's shares have fluctuated over the last five days.
Centinel Spine has launched a patient access program to increase reimbursement support for two-level Prodisc L lumbar total disc replacement, according to an Oct. 27 announcement.
Medical device company Titan Medical will receive $10 million after completing the first technical milestone under its development and licensing agreement with Medtronic.
